Abbott Laboratories (ABT)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
At a market value of $171.7B, Abbott Laboratories's free cash flow of $7.4B (fiscal 2025) would need to grow about 7% a year for the stock to be worth today's price. That is slower than the company has grown its free cash flow over the last 9 years.
Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Abbott Laboratories's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.
Fundamental grade
Five factors scored 1 to 9 from ABT's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Abbott Laboratories's 10-K filings. The deep dive has 15+ years, quarters and every line.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $43.1B | $43.7B | $40.1B | $42.0B | $44.3B |
| Net income | $7.1B | $6.9B | $5.7B | $13.4B | $6.5B |
| Free cash flow | $8.6B | $7.8B | $5.1B | $6.4B | $7.4B |
| EPS (diluted) | $3.94 | $3.91 | $3.26 | $7.64 | $3.72 |
| Operating margin | 19.6% | 19.2% | 16.2% | 16.3% | 18.2% |
Where the revenue comes from
Revenue by segments, fiscal 2025.
Superinvestors who own ABT
From each investor's latest 13F filing (what a 13F shows). 11 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Ric Dillon Diamond Hill Capital Management |
Trimmed | $448M | 3.6% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | $380M | 0.13% | Q2 2026 |
| Mason Hawkins Southeastern Asset Management |
New position | $76M | 4.0% | Q2 2026 |
| PRIMECAP Management PRIMECAP Management Co |
Trimmed | $69M | 0.04% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | $44M | 0.10% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | $5M | 0.00% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Trimmed | $2M | 0.02% | Q2 2026 |
| Eric Marshall Hodges Capital Management |
New position | $2M | 0.13% | Q2 2026 |
| Dodge & Cox Dodge & Cox |
Held | $2M | 0.00% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Added | $881,630 | 0.01% | Q2 2026 |
| Will Nasgovitz Heartland Advisors |
Held | $122,499 | 0.00% | Q2 2026 |
Insider buying
Open-market purchases by Abbott Laboratories's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 23, 2026 | Ro Khanna |
0 | $104.87 | — |
| Mar 23, 2026 | Ro Khanna |
0 | $104.87 | — |
| Mar 19, 2026 | Richard Mccormick |
0 | $107.16 | — |
| Mar 19, 2026 | Richard Mccormick |
0 | $107.16 | — |
| Mar 10, 2026 | Ro Khanna |
0 | $110.60 | — |
| Mar 10, 2026 | Ro Khanna |
0 | $110.60 | — |
| Feb 24, 2026 | Ro Khanna |
0 | $114.65 | — |
| Feb 24, 2026 | Ro Khanna |
0 | $114.65 | — |
| Feb 5, 2026 | Michael T. Mccaul |
0 | $109.03 | — |
| Feb 5, 2026 | Michael T. Mccaul |
0 | $109.03 | — |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when ABT trades at or below it.
Free accounts get 3 price alerts. No card needed.
In the full deep dive
Questions
What growth does Abbott Laboratories's stock price imply?
At a market value of $171.7B, Abbott Laboratories would need its free cash flow to grow about 7% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 15% a year.
Are Abbott Laboratories insiders buying the stock?
10 open-market insider purchases of ABT in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Abbott Laboratories?
11 of the superinvestors Investingly tracks hold ABT in their latest 13F, including Ric Dillon, Cliff Asness, Mason Hawkins.
Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.